Description
+ Include: 10 videos + 24 pdfs, size: 3.88 GB
+ Target Audience: nephrologists, rheumatologists, cardiologists, hepatologists, intensive care specialists, internists
+ Sample video: contact me for sample video
+ Information:
Overview
Thank you for joining your colleagues for the Cleveland Clinic Nephrology Update 2024. This year’s update will provide a review of the most up-to-date data and analyze it for implications in clinical practice, as well as focus on the most recent current topics that impact your practice. Cleveland Clinic Nephrology Update 2024 features experts that will address diagnosis and management strategies for patients with kidney disease.
Target Audience
This activity is designed for nephrologists, rheumatologists, cardiologists, hepatologists, intensive care specialists, internists, nurses, nurse practitioners, physician assistants, and all other clinicians who care for these patients.
Learning Objectives
- Describe the role of precision medicine in the care of patients with genetic kidney diseases, and describe the major hereditary renal syndromes.
- Summarize the most recent advances in the treatment of polycystic kidney disease.
- Identify the management strategies of hepatorenal syndrome, including therapies such as MARS, Terlipressin, and CRRT.
- Describe and critically appraise several updates in nephrology, including future therapies of C3GN, the pathogenesis and management of IgA nephropathy, and the major advances in the field of kidney transplantation.
- Identify controversies in the management of ANCA-associated vasculitis as well as the role of emerging therapies.
- Describe the role of the complement pathway in the development of thrombotic microangiopathy.
- Recognize the different facets of glomerular disease management beyond immuno-modulatory therapy.
- Summarize the emerging pharmacological and procedural therapies in hypertension management.
- Review the clinical guidelines for screening and management of primary hyperaldosteronism.
- Examine the updated management guidelines for obesity management in CKD patients, including the role of SGLT2i and GLP1-RA.
+ Topics:
April 18 ADPKD Update.pdf
April 18 Cleveland Clinic Nephrology Update Journal Club.pdf
April 18 Genetics in Tubulointerstitial Atypical Cystic Disease Kidney Stones.pdf
April 18 Genetics Program Overview Pre Post Counseling.pdf
April 18 Precision Medicine Genetics and Nephrology.pdf
April 19 ANCA Vasculitis Update on Management and Controversies.pdf
April 19 Cardiac Axis in HRS The Hepato-Cardio-Renal Syndrome.pdf
April 19 Case Discussions in AKI and Cirrhosis in the ICU MARS Terlipressin RRT.pdf
April 19 Clinicopathologic Case Discussions 1.pdf
April 19 Clinicopathologic Case Discussions 2.pdf
April 19 HRS Update.pdf
April 19 IgA Nephropathy Update.pdf
April 19 Kasperzak Lecture Lupus Nephritis Update.pdf
April 19 Nephrology-Rheumatology Case Discussions.pdf
April 19 Prophylaxis in Glomerular Diseases.pdf
April 19 Thrombotic Microangiopathy and Complement Immunology.pdf
April 19 Update on C3 Glomerulopathy.pdf
April 20 Challenging Hypertension Cases Panel Discussion.pdf
April 20 Emerging Pharmacologic Therapies in Hypertension.pdf
April 20 Obesity and CKD.pdf
April 20 Prescribing GLP1-RA and SGLT2i A Practical Guide for the Nephrologist.pdf
April 20 Procedural Therapies for Hypertension An Update.pdf
April 20 Update on Hyperaldosteronism.pdf
April 20 Update on Obesity Management.pdf
Chronic Kidney Disease Part 1.mp4
Chronic Kidney Disease Part 2.mp4
Cleveland Clinic Nephrology Update Journal Club- Jagmeet Dhingra, MD and Jonathan Taliercio, DO.mp4
Genetics and Precision Nephrology.mp4
Liver-Kidney Conundrum Part 1.mp4
Liver-Kidney Conundrum Part 2.mp4
Update in Glomerulopathies Part 1.mp4
Update in Glomerulopathies Part 2.mp4
Updates in Hypertension Part 1.mp4
Updates in Hypertension Part 2.mp4
Reviews
There are no reviews yet.